Cytecom
Higher Education
Venture roundlatest round · Mar 2026 · 7 mo ago
1backers · Oxford Technology
$200kgrants · 2 grants · CORDIS
2018founded
Overview
Cytecom has created a groundbreaking approach to diagnosing bacterial infections. Ensuring the correct antibiotic is prescribed every time.
Official records
Funding and backers
Latest round
Venture round
Mar 2026 · 7 mo ago
Grants
$200k
2 grants · CORDIS
Backers
1
Oxford Technology
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 30
Raised a round Venture round
May 1, 2024
Won a grant $17k · CORDIS
Mar 28, 2024
Raised a round Venture round
Dec 28, 2023
Raised a round Venture round
Jun 15, 2022
Raised a round Venture round
Apr 7, 2021
Raised a round Venture round
Dec 11, 2019
Raised a round Venture round
Nov 1, 2018
Won a grant $183k · CORDIS
Mar 20, 2018
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | May 2024 | $17k | — | CORDIS |
| Venture round | Mar 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jun 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Apr 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2019 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Nov 2018 | $183k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | CYTECOM LTD | Companies House |
| Registered | 20 Mar 2018 |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs SurgeCare
Similar startupsby what they do, their industry and backers
Sabiad is a pioneer in infection diagnostics and theranostics for bacterial infections. We offer solutions for Staphylococcus aureus and…
For the first time you CAN personalize learning at scale. Experience our evidence-based approach to student-centered learning.
Amprologix is pioneering a family of new antibiotics to combat the growing threat of antimicrobial resistance.
Saving lives through antibiotic sensitivity precision diagnostics. 1-hour UTI detection & antibiotic sensitivity indication.
A radically new approach to integrity in writing focusing on the writing process. An effort-focused alternative to Turnitin and AI…
Company Technology Application Contact Company ArtiFex Medical GmbH, founded in 2020 in Vienna as a spin-off from University Hospital…
Financials
Total raised
$200k
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | — | Details |
| Grant | 2024 | $17k | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2022 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2019 | — | Details |
| Grant | 2018 | $183k | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Oxford TechnologyVia a fund
58 portfolio companies: asymmetricsuzuki.co.uk, Electrowinning Technologies Ltd, Pi seal and 55 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Parallelised detection of bacteria viability using an electrode array and the Exeter Multiscope
Antimicrobial resistance remains a global existential threat. Given that antimicrobial therapy commonly starts before pathogen identification, rapid and scalable methods capable of determining effective antimicrobial compounds are needed. In this paper, w
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Coventry
United Kingdom
HQ